NCT02260830

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

Interventional, Open-label, Part Fixed Sequence, Part-randomised Study Investigating the Pharmacokinetic Properties of up to 6 Prototype Modified Release Tablet Formulations of Lu AF11167 in Healthy Young Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: H. Lundbeck A/S · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) properties of a modified release tablet formulation of Lu AF11167 in a fed and fasted state and following multiple dosing (Part B).

Conditions

• Schizophrenia

Interventions

Type	Name	Description
DRUG	Lu AF11167

Timeline

• Start date: 2014-08-01
• Primary completion: 2015-03-01
• First posted: 2014-10-09
• Last updated: 2015-03-06

Locations

1 site across 1 country: United Kingdom